The Efficacy and Response Predictors of Platinum-Based Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer.
Yuhui HuangLin LiuJing CaiLu YangSi SunJing ZhaoZhoufang XiongZehua WangPublished in: Cancer management and research (2020)
The response rate of platinum-based NACT was approximately 60%. The response to NACT was an independent risk factor for prognosis, and patients with earlier stage and smaller tumor tended to respond better to NACT.